Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses-Reference-Cited by-同舟云学术

Sarcomatoid hepatocellular carcinoma is distinct from ordinary hepatocellular carcinoma: Clinicopathologic, transcriptomic and immunologic analyses

Published:2021-03-13 Issue:3 Volume:149 Page:546-560
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Morisue Ryo¹²³^ORCID,Kojima Motohiro⁴^ORCID,Suzuki Toshihiro⁴⁵,Nakatsura Tetsuya⁴,Ojima Hidenori⁶,Watanabe Reiko³⁷,Sugimoto Motokazu¹,Kobayashi Shin¹,Takahashi Shinichiro¹,Konishi Masaru¹,Ishii Genichiro³⁷^ORCID,Gotohda Naoto¹,Fujiwara Toshiyoshi²^ORCID,Ochiai Atsushi⁸

Affiliation:

1. Department of Hepatobiliary and Pancreatic Surgery National Cancer Center Hospital East Kashiwa Japan

2. Department of Gastroenterological Surgery Transplant and Surgical Oncology Okayama University Graduate School of Medicine Dentistry and Pharmaceutical Sciences Okayama Japan

3. Division of Pathology, Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

4. Division of Cancer Immunotherapy Exploratory Oncology Research & Clinical Trial Center, National Cancer Center Kashiwa Japan

5. General Medical Education and Research Center Teikyo University Tokyo Japan

6. Department of Pathology Keio University School of Medicine Tokyo Japan

7. Department of Pathology and Clinical Laboratories National Cancer Center Hospital East Kashiwa Japan

8. Exploratory Oncology Research & Clinical Trial Center National Cancer Center Kashiwa Japan

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.33545

Reference50 articles.

1. Morphologic Subtypes of Hepatocellular Carcinoma

2. Hepatocellular carcinoma with sarcomatous change. Clinicopathologic and immunohistochemical studies of 14 autopsy cases

3. Hepatocellular carcinoma with sarcomatous change: a special reference to the relationship with anticancer therapy

4. Hepatocellular carcinoma with sarcomatous change;Yamaguchi R;Oncol Rep,1997

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment and Prognostic Implications of Strong PD-L1 Expression in Primary Hepatic Sarcomatoid Carcinoma;Immunotherapy;2024-02-16

2. Downregulated expression of PBRM1 in sarcomatoid hepatocellular carcinoma;Oncology Letters;2024-01-26

3. Surgery after combination therapy with a tyrosine kinase inhibitor and anti-PD-1 antibody in sarcomatoid hepatocellular carcinoma: case report and literature review;Frontiers in Oncology;2023-10-05

4. Common clinicopathological and immunological features of sarcomatoid carcinoma across organs: A histomorphology‐based cross‐organ study;International Journal of Cancer;2023-08-07

5. Immune checkpoint inhibitors in hepatocellular carcinoma: emerging challenges in clinical practice;The Lancet Gastroenterology & Hepatology;2023-08